Impiricus
The future of HCP-Pharma connectivity. Impiricus is the HCP-preferred platform to engage with Pharma.
The future of HCP-Pharma connectivity. Impiricus is the HCP-preferred platform to engage with Pharma.
Impiricus is a healthcare technology startup founded in 2021 and headquartered in United States. The company's slogan "The future of HCP-Pharma connectivity. Impiricus is the HCP-preferred platform to engage with Pharma." highlights its focus on revolutionizing the interaction model between Healthcare Professionals (HCPs) and pharmaceutical companies. Impiricus aims to be the single hub for HCPs when interacting with the industry on-demand, offering elegant tools that HCPs love. Its mission is to connect healthcare professionals to the resources that give their patients the best access to care, thereby creating value for all stakeholders in healthcare delivery.
Impiricus recently secured a $3.00M Seed Round investment on 26 April 2022, with funding coming from notable investors including FCA Venture Partners and Surface Ventures. The company's model, which prioritizes the preferences of HCPs and enhances the engagement process with pharma companies, shows promising potential in the rapidly evolving healthcare and pharmaceutical industries.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $3.00M | 2 |
|
26 Apr 2022 |
| Pre Seed Round | $485.00K | 1 |
|
04 Apr 2021 |
No recent news or press coverage available for Impiricus.
We care about your data, and we'd love to use cookies make your experience better.
